[ET Net News Agency, 30 October 2017] Goldman Sachs raised its target price for Health
& Happiness Intl Holdings (H&H)(01112) to HK$30 from HK$27.5, and maintained its "neutral"
rating.
The research house said H&H's 3Q operational updates are ahead of GS's expectations.
Goldman raised its 2017-19 EPS forecasts by 4-10% to reflect faster infant formula sales
from the super premium segment, strong probiotics and higher Swisse sales as they have a
good run-rate heading into the 4Q peak season.
It said the key focus for now is sales growth during the Singles' Day festival. The
company has flagged a solid pre-sales trend for now in Tmall (ranked No.1 in supplements),
but some demand has been pushed forward to September this year. Hence Goldman sees likely
20% sales growth yoy for 4Q. (KL)
|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01112 H&H INTL HLDG
Nominal 
10.160 0.000 (0.000%) Others
31/10/2017 17:38
[I-bank focus]Goldman lifts H&H Int'l Hldg (01112) to HK$30
| Remark: | Real time quote last updated: 23/04/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service |